-
3,13,21-triazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one
-
ChemBase ID:
72975
-
Molecular Formular:
C18H13N3O
-
Molecular Mass:
287.31532
-
Monoisotopic Mass:
287.10586205
-
SMILES and InChIs
SMILES:
n12c(nc3c(c1=O)cccc3)c1c(CC2)c2c([nH]1)cccc2
Canonical SMILES:
O=c1c2ccccc2nc2n1CCc1c2[nH]c2c1cccc2
InChI:
InChI=1S/C18H13N3O/c22-18-13-6-2-4-8-15(13)20-17-16-12(9-10-21(17)18)11-5-1-3-7-14(11)19-16/h1-8,19H,9-10H2
InChIKey:
ACVGWSKVRYFWRP-UHFFFAOYSA-N
-
Cite this record
CBID:72975 http://www.chembase.cn/molecule-72975.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
3,13,21-triazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one
|
3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one
|
|
|
IUPAC Traditional name
|
rutaecarpine
|
3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one
|
|
|
Synonyms
|
Rutecarpine
|
Rutacarpine
|
Rutaecarpin
|
Rhetine
|
Rutaecarpine
|
7,8-dihydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(13H)-one
|
8,13-Dihydro-indolo[2′,3′:3,4]pyrido[2,1-b]quinazolin-5(7H)-one
|
Rutaecarpine
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
13.441173
|
H Acceptors
|
2
|
H Donor
|
1
|
LogD (pH = 5.5)
|
2.9095914
|
LogD (pH = 7.4)
|
2.9099379
|
Log P
|
2.9099426
|
Molar Refractivity
|
87.2307 cm3
|
Polarizability
|
32.738087 Å3
|
Polar Surface Area
|
48.46 Å2
|
Rotatable Bonds
|
0
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Selleck Chemicals
InterBioScreen
Sigma Aldrich
Selleck Chemicals -
S2349
|
Research Area: Cardiovascular Disease , Inflammation , Neurological Disease Biological Activity: Rutaecarpine is an indolopyridoquinazolinone alkaloid isolated from Evodia rutaecarpa and related herbs, which has shown a variety of intriguing biological properties such as anti-thrombotic, anticancer, anti-inflammatory and analgesic, anti-obesity and thermoregulatory, vasorelaxing activity, as well as effects on the cardiovascular and endocrine systems. [1] |
Sigma Aldrich -
R3277
|
Biochem/physiol Actions Delayed rectifier K+ channel blocker. Inhibits platelet aggregation; vasoldilator. |
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • www.mdpi.com/1420-3049/13/2/272/pdf
- • Yamazaki, M. et al., Tet. Lett., 1966, 3221; 1967, 3317
- • Chiou, W.-F. et al., Eur. J. Pharmacol., 1994, 257, 59
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent